United Therapeutics (UTHR) Misses Q4 EPS by 8c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $538.30 +0.32%
EPS Growth %: +12.6%
Financial Fact:
Selling, general and administrative: 100.1M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +12.6%
Financial Fact:
Selling, general and administrative: 100.1M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $4.36, $0.08 worse than the analyst estimate of $4.44. Revenue for the quarter came in at $614.7 million versus the consensus estimate of $575.1 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- NVE Corporation names new CEO and expands board to seven members
- Pfizer lung cancer drug misses survival goal in Phase 3 trial
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
